FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.)

FDA D.I.S.C.O.: Niraparib in Ovarian Cancer Transcript


Listen Later

FDA medical oncologists discuss the agency’s March 2017 approval of niraparib for the maintenance treatment of patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in complete or partial response to platinum-based chemotherapy.
...more
View all episodesView all episodes
Download on the App Store

FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.)By U.S. Food and Drug Administration, Center for Drug Evaluation and Research

  • 4.4
  • 4.4
  • 4.4
  • 4.4
  • 4.4

4.4

14 ratings